Literature DB >> 18794361

Transforming growth factor beta-induced Smad1/5 phosphorylation in epithelial cells is mediated by novel receptor complexes and is essential for anchorage-independent growth.

Amanda C Daly1, Rebecca A Randall, Caroline S Hill.   

Abstract

Transforming growth factor beta (TGF-beta) signals predominantly through a receptor complex comprising ALK5 and TbetaRII to activate receptor-regulated Smads (R-Smads) Smad2 and Smad3. In endothelial cells, however, TGF-beta can additionally activate Smad1 and Smad5. Here, we report that TGF-beta also strongly induces phosphorylation of Smad1/5 in many different normal epithelial cells, epithelium-derived tumor cells, and fibroblasts. We demonstrate that TbetaRII and ALK5, as well as ALK2 and/or ALK3, are required for TGF-beta-induced Smad1/5 phosphorylation. We show that the simultaneous activation of the R-Smads Smad2/3 and Smad1/5 by TGF-beta results in the formation of mixed R-Smad complexes, containing, for example, phosphorylated Smad1 and Smad2. The prevalence of these mixed R-Smad complexes explains why TGF-beta-induced Smad1/5 phosphorylation does not result in transcriptional activation via bone morphogenetic protein (BMP)-responsive elements, which bind activated Smad1/5-Smad4 complexes that are induced by BMP stimulation. Thus, TGF-beta induces two parallel pathways: one signaling via Smad2-Smad4 or Smad3-Smad4 complexes and the other signaling via mixed R-Smad complexes. Finally, we assess the function of the novel arm of TGF-beta signaling and show that TGF-beta-induced Smad1/5 activation is not required for the growth-inhibitory effects of TGF-beta but is specifically required for TGF-beta-induced anchorage-independent growth.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18794361      PMCID: PMC2573298          DOI: 10.1128/MCB.01192-08

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  46 in total

1.  Homeodomain and winged-helix transcription factors recruit activated Smads to distinct promoter elements via a common Smad interaction motif.

Authors:  S Germain; M Howell; G M Esslemont; C S Hill
Journal:  Genes Dev       Date:  2000-02-15       Impact factor: 11.361

2.  Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures.

Authors:  Jayanta Debnath; Senthil K Muthuswamy; Joan S Brugge
Journal:  Methods       Date:  2003-07       Impact factor: 3.608

3.  Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter.

Authors:  Olexander Korchynskyi; Peter ten Dijke
Journal:  J Biol Chem       Date:  2001-11-29       Impact factor: 5.157

Review 4.  How cells read TGF-beta signals.

Authors:  J Massagué
Journal:  Nat Rev Mol Cell Biol       Date:  2000-12       Impact factor: 94.444

5.  The L45 loop in type I receptors for TGF-beta family members is a critical determinant in specifying Smad isoform activation.

Authors:  U Persson; H Izumi; S Souchelnytskyi; S Itoh; S Grimsby; U Engström; C H Heldin; K Funa; P ten Dijke
Journal:  FEBS Lett       Date:  1998-08-28       Impact factor: 4.124

6.  Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors.

Authors:  Marie-José Goumans; Gudrun Valdimarsdottir; Susumu Itoh; Alexander Rosendahl; Paschalis Sideras; Peter ten Dijke
Journal:  EMBO J       Date:  2002-04-02       Impact factor: 11.598

7.  TGF-beta inhibits p70 S6 kinase via protein phosphatase 2A to induce G(1) arrest.

Authors:  C Petritsch; H Beug; A Balmain; M Oft
Journal:  Genes Dev       Date:  2000-12-15       Impact factor: 11.361

8.  Nucleocytoplasmic shuttling of Smads 2, 3, and 4 permits sensing of TGF-beta receptor activity.

Authors:  Gareth J Inman; Francisco J Nicolás; Caroline S Hill
Journal:  Mol Cell       Date:  2002-08       Impact factor: 17.970

9.  SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7.

Authors:  Gareth J Inman; Francisco J Nicolás; James F Callahan; John D Harling; Laramie M Gaster; Alastair D Reith; Nicholas J Laping; Caroline S Hill
Journal:  Mol Pharmacol       Date:  2002-07       Impact factor: 4.436

Review 10.  Controlling the angiogenic switch: a balance between two distinct TGF-b receptor signaling pathways.

Authors:  Marie-Jose Goumans; Franck Lebrin; Gudrun Valdimarsdottir
Journal:  Trends Cardiovasc Med       Date:  2003-10       Impact factor: 6.677

View more
  145 in total

Review 1.  Transforming growth factor beta signaling in adult cardiovascular diseases and repair.

Authors:  Thomas Doetschman; Joey V Barnett; Raymond B Runyan; Todd D Camenisch; Ronald L Heimark; Henk L Granzier; Simon J Conway; Mohamad Azhar
Journal:  Cell Tissue Res       Date:  2011-09-28       Impact factor: 5.249

2.  Mechanisms of TGF-β-induced differentiation in human vascular smooth muscle cells.

Authors:  Yuefeng Tang; Xuehui Yang; Robert E Friesel; Calvin P H Vary; Lucy Liaw
Journal:  J Vasc Res       Date:  2011-08-11       Impact factor: 1.934

3.  Runx2-I is an Early Regulator of Epithelial-Mesenchymal Cell Transition in the Chick Embryo.

Authors:  Andre L P Tavares; Jessie A Brown; Emily C Ulrich; Katerina Dvorak; Raymond B Runyan
Journal:  Dev Dyn       Date:  2017-07-19       Impact factor: 3.780

Review 4.  The changing role of TGFβ in healthy, ageing and osteoarthritic joints.

Authors:  Peter M van der Kraan
Journal:  Nat Rev Rheumatol       Date:  2017-02-02       Impact factor: 20.543

5.  Computational modelling of Smad-mediated negative feedback and crosstalk in the TGF-β superfamily network.

Authors:  Daniel Nicklas; Leonor Saiz
Journal:  J R Soc Interface       Date:  2013-06-26       Impact factor: 4.118

Review 6.  The role of activin in mammary gland development and oncogenesis.

Authors:  Karen A Dunphy; Alan L Schneyer; Mary J Hagen; D Joseph Jerry
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-04-08       Impact factor: 2.673

Review 7.  Transforming growth factor beta (TGF-beta) and inflammation in cancer.

Authors:  Brian Bierie; Harold L Moses
Journal:  Cytokine Growth Factor Rev       Date:  2009-12-16       Impact factor: 7.638

Review 8.  Beyond TGFβ: roles of other TGFβ superfamily members in cancer.

Authors:  Lalage M Wakefield; Caroline S Hill
Journal:  Nat Rev Cancer       Date:  2013-05       Impact factor: 60.716

9.  Targeting the Transforming Growth Factor-beta pathway inhibits human basal-like breast cancer metastasis.

Authors:  Vidya Ganapathy; Rongrong Ge; Alison Grazioli; Wen Xie; Whitney Banach-Petrosky; Yibin Kang; Scott Lonning; John McPherson; Jonathan M Yingling; Swati Biswas; Gregory R Mundy; Michael Reiss
Journal:  Mol Cancer       Date:  2010-05-26       Impact factor: 27.401

10.  Drosophila Smad2 opposes Mad signaling during wing vein development.

Authors:  Veronika Sander; Edward Eivers; Renee H Choi; Edward M De Robertis
Journal:  PLoS One       Date:  2010-04-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.